Neurosurg Focus 44 (6): E6, 2018 M icroscope-integrated indocyanine green videoangiography (ICG-VA) has been introduced in vascular neurosurgery in order to visualize cerebral vessels during surgical management of different vascular pathologies. 3, 8, 9, 12, [14] [15] [16] [17] [18] [19] 23, 27, 28, [30] [31] [32] Furthermore, ICG-VA has been proven to be a useful adjunct for intraoperative study of venous flow dynamics, in both pathological 30,33 and normal veins, 35 and for evaluation of the possibility of venous sacrifice during surgical approaches to different pathologies. 35, 38 ABBREVIATIONS AI = arbitrary intensity unit; AVF = arteriovenous fistula; GBM = glioblastoma; ICA = internal carotid artery; ICG-VA = indocyanine green videoangiography; MCA = middle cerebral artery; PCoA = posterior communicating artery; ROI = region of interest; SSS = superior sagittal sinus. OBJECTIVE Indocyanine green videoangiography (ICG-VA) is an intraoperative technique used to highlight vessels in neurovascular surgery. Its application in the study of the vascular pathophysiology in CNS tumors and its role in their surgical management are still rather limited. A recent innovation of ICG-VA (i.e., the FLOW 800 algorithm integrated in the surgical microscope) allows a semiquantitative evaluation of cerebral blood flow. The aim of this study was to evaluate for the first time the systematic application of ICG-VA and FLOW 800 analysis during surgical removal of CNS tumors. METHODS Between May 2011 and December 2017, all cases in which ICG-VA and FLOW 800 analysis were used at least one time before, during, or after the tumor resection, and in which surgical videos were available, were retrospectively reviewed. Results of the histological analysis were analyzed together with the intraoperative ICG-VA with FLOW 800 in order to investigate the tumor-related videoangiographic features. RESULTS Seventy-one patients who underwent surgery for cerebral and spinal tumors were intraoperatively analyzed using ICG-VA with FLOW 800, either before or after tumor resection, for a total of 93 videoangiographic studies. The histological diagnosis was meningioma in 25 cases, glioma in 14, metastasis in 7, pineal region tumor in 5, hemangioblastoma in 4, chordoma in 3, and other histological types in 13 cases. The authors identified 4 possible applications of ICG-VA and FLOW 800 in CNS tumor surgery: extradural surveys allowed exploration of sinus patency and the course of veins before dural opening; preresection surveys helped in identifying pathological vascularization (arteriovenous fistulas and neo-angiogenesis) and regional venous outflow, and in performing temporary venous clipping tests, when necessary; postresection surveys were conducted to evaluate arterial and venous patency and parenchymal perfusion after tumor removal; and a premyelotomy survey was conducted in intramedullary tumors to highlight the posterior median sulcus. CONCLUSIONS The authors found ICG-VA with FLOW 800 to be a useful method to monitor blood flow in the exposed vessels and parenchyma during microsurgical removal of CNS tumors in selected cases. In particular, a preresection survey provides useful information about pathophysiological changes of brain vasculature related to the tumor and aids in the individuation of helpful landmarks for the surgical approach, and the postresection survey helps to prevent potential complications associated with the resection (such as local hypoperfusion or venous infarction).
In 2011, we were the first group to propose the standard use of ICG-VA to study the vascular pathophysiology in CNS tumors and its role in their surgical management. 13 Since then, very few reports on the application of ICG-VA in the context of CNS tumor resection have been published. 7, 10, 20, 22, 24, 27, 36, 37 More recently, a further development of the software integrated in surgical microscopes (FLOW 800 Software Analysis Tool, Pentero and Kinevo microscopes; Carl Zeiss Co.) allowed investigators to perform a postprocessing semiquantitative analysis of blood flow in arteries, brain parenchyma, and veins, derived from the classic ICG-VA. 3, 24 In this study, we evaluated for the first time the systematic application of ICG-VA with FLOW 800 analysis in a retrospective series of patients who underwent surgical removal of cerebral and spinal tumors.
Methods

Patient Population
In the period between May 2011 and December 2017, 1443 patients underwent surgical removal of a CNS tumor at the Neurosurgical Unit II of the Fondazione IRCCS "Istituto Neurologico Carlo Besta." Of these, all cases in which ICG-VA and FLOW 800 analysis were used at least one time before or after the tumor resection, and whose surgical videos and FLOW 800 analysis were available, were retrospectively reviewed in order to explore the different specific applications of this technique during surgical removal of CNS tumors. All patients gave their informed consent to the use of ICG-VA. The surgical database of the Neurosurgical Unit II has been approved by our ethics committee.
Surgery and Postoperative Management
All patients received a standard preoperative evaluation, including blood testing and general and neurological clinical assessment. All of them underwent a preoperative MRI session, including standard sequences for brain and spinal tumors. Tumor removal was performed with standard technique based on the lesion's location, including the use of neuronavigation, ultrasound, photodynamic detection (tumors were visualized using a fluorescein-guided technique, with the dose of 5 mg/kg, following the recommendation of the FLUOCERTUM study, approved by our ethics committee in 2016), 1 
The ICG-VA With FLOW 800 Analysis
The ICG-VA was performed as previously described. 3, 12, 14 Briefly, ICG was administered intravenously by the anesthesiologist upon the surgeon's request, with a standard dose of 12.5 mg in a single bolus, before dural opening, immediately before or after tumor resection. Multiple injections were performed in selected cases, never exceeding the maximum daily dose of 5 mg/kg.
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The flow analysis was based on the use of FLOW 800 software, which was integrated in the surgical microscope (Pentero; Carl Zeiss Meditec). The algorithm calculated fluorescence intensities in the exposed areas based on the average arbitrary intensity units (AIs) detected by the camera and reconstructed maps of maximal fluorescence intensities and of delay times (time interval until 50% of maximum fluorescence). Specifically, the maps were shown as gray scale of maximal fluorescence intensities and as color scale, depending on time to half-maximal fluorescence. In addition, the course of fluorescence could be further analyzed in any area of the exposed brain, including parenchyma, by using freely definable regions of interest (ROIs) (Fig. 1) .
Results
Patients and CNS Tumors
A total of 71 cases have been included in this retrospective analysis. There were 61 intracranial tumors: 12 high-grade gliomas (11 glioblastomas [GBMs] and 1 anaplastic oligodendroglioma), 1 low-grade glioma (grade II oligodendroglioma), 2 central neurocytomas, 1 pleomorphic xanthoastrocytoma, 7 metastases, 25 meningiomas (24 grade I and 1 grade II), 5 tumors of the pineal region (4 grade II and 1 grade III pineal parenchymal tumors of intermediate differentiation), 3 chordomas, 1 craniopharyngioma, 3 hemangioblastomas, 1 giant angioma of the cavernous sinus; and 10 spinal cord lesions: 5 ependymomas, 1 pilocytic astrocytoma, 1 neuroendocrine tumor, 1 enterogenic cyst, 1 schwannoma, and 1 hemangioblastoma (Table 1) . In 20 cases, the fluorescein-guided technique was used to better visualize and remove the intrinsic tumors enhancing on preoperative MRI.
Applications of ICG-VA With FLOW 800 in CNS Tumor Resection
General Considerations
The ICG-VA could be performed in all cases, with optimal visualization of arterial, capillary-parenchymal, and venous phases, even in the 20 cases in which the fluorescein-guided technique was used to remove the tumors. No difficulties of tumor visualization with fluorescein due to the simultaneous use of ICG-VA could be detected. In all patients at least 1 injection was performed either before or after tumor resection, with 17 patients receiving multiple injections (3 times in 5 patients, 2 times in the remaining cases), for a total of 93 ICG-VA studies (Table 1) . No adverse reactions to ICG injections were observed.
Different Applications of ICG-VA During CNS Tumor Resection
Extradural Survey Before Dural Opening. The ICG-VA was used extradurally in 6 cases (4 meningiomas, 1 oligodendroglioma, and 1 metastasis). In particular, ICG-VA was used in 3 cases (2 parasagittal meningiomas and 1 oligodendroglioma) to show the course of parasagittal cortical veins before dural opening. In 2 torcular meningiomas, ICG-VA showed both the position and patency of the transverse sinus before dural opening. In one case of bulbar metastasis, the use of ICG-VA demonstrated the possibility of sigmoid sinus sacrifice (presence of retrograde flow) for a petro-occipital transsigmoidal surgical route to approach the lesion. We did not find a specific advantage related to the use of FLOW 800 analysis for extradural surveys, due to the fact that all the information could be retrieved with the maps of gray intensity as in classic ICG-VA (Fig. 2) .
Preresection Survey. The ICG-VA was performed in 27 cases (37 ICG-VAs) before tumor resection. For parenchymal tumors reaching the brain surface, a superficial vascular survey was used to demonstrate areas of neo-angiogenesis with pathological vessels related to the tumor, or the presence of arteriovenous fistulas (AVFs), with vein flow disturbances in 3 cases of GBM, 3 cases of hemangioblastoma (2 cerebellar, 1 cervical), 1 tumor of the pineal region, 1 lumbar intradural neuroendocrine tumor, 1 cervical intradural schwannoma, 1 pleomorphic xanthoastrocytoma, and 1 metastasis (Figs. 3 and 4A-C) . In all these cases FLOW 800 analysis allowed investigators to better distinguish the border of the tumors related to neo-angiogenesis and pathological vessels, based on maps of delay time, or the presence of AVFs, both with maps of delay times and analysis of flow curves. In the tumor cases treated with fluorescein-guided removal, 1,2,5 the neoangiogenesis shown on maps of delay times corresponded to the areas highlighted by fluorescein (Fig. 3) .
In 4 cases (1 meningioma, 2 GBMs, 1 metastasis) ICG-VA showed brain congestion, with a delay of flow particularly in the parenchymal phase due to compression by the
FIG. 1.
Example of ICG-VA and FLOW 800 analysis in a case of left temporal metastases from adenocarcinoma (inset: the preoperative MR image). In a white-light microscopy view (A), the superficial projection of the tumor is identified by neuronavigation, as depicted by the asterisk. The ICG FLOW 800 algorithm is able to reconstruct the map of fluorescence intensity (C) based on intensity detected by the camera and graded by the average AIs and the map of delay time (B) based on the time to the half-maximal fluorescence in the area exposed by the craniotomy. In this way, arteries are represented in red (dashed arrow), veins in blue (white arrow), and the arterialized portion of the veins in gray/yellow (black arrow). The software also makes it possible to study different ROIs in the map of gray intensity, with automatic reconstruction of flow curves over time, as depicted in D. In the graph of this example, the arterial curve is shown in red; the venous curve in blue; and the arterialized part of the vein, with faster flow than normal veins, in green.
tumor (1 of the GBMs also presented with vein arterialization) ( Fig. 4A-C) . The use of FLOW 800 analysis, even if it was not essential to show the brain congestion related to the presence of the tumor, allowed us to identify a slower time to peak due to brain congestion in postprocessing analysis; if repeated postresection, the same analysis could show a steeper flow curve, indicating an improvement of cortical flow (Fig. 4) .
In 1 case of recurrent chordoma, a preresection ICG-VA session was performed to verify the patency and flow characteristics of a vertebral artery that was stenotic due to previous surgery and irradiation. For this last instance, we did not find a specific advantage in the use of FLOW 800 analysis.
In 2 cases (1 pineal tumor with 2 injections and 1 parasagittal meningioma) the preresection survey was used to study, with the maps of delay times and flow analysis derived from FLOW 800 software, the specific flow in the veins encountered during the approach (supracerebellar and precerebellar in the case of the pineal tumor), or in the vein completely encased by the tumor (the parasagittal meningioma).
In 9 cases a temporary ICG-VA clipping test was performed to evaluate the possibility of venous sacrifice to either enlarge the surgical corridor to the tumor or completely remove it, as previously described. 14, 15 Briefly, a preclipping ICG-VA study was used to study the basal venous flow, and then it was repeated after temporary clipping of the vein to be potentially sacrificed in order to check for the presence of anastomotic circulation. A total of 18 ICGVAs were therefore performed in this group of patients. In 4 cases (1 intraventricular neurocytoma, 1 frontal metastasis, 1 frontal GBM, 1 meningioma) the test was performed on parasagittal veins draining to the superior sagittal sinus (SSS), that either were obstructing the surgical corridor (the first 3 cases) or were encased by the tumor (the last case of parasagittal meningioma). In 3 cases the postclipping ICG- 
FIG. 2. Extradural survey. A and B:
A case of infra-and supratentorial meningioma involving the torcular in which the extradural examination revealed the transverse sinus (TS) between the occipital lobe (Occ) and cerebellar parenchyma. C and D: A case of left frontal oligodendroglioma in which it was possible to identify the SSS and a cortical vein (arrow) draining into the SSS, that was not clearly identifiable in white light (C). The ICG-VA, also with simple maps of gray intensity, guided dural opening, avoiding damage to the sinuses and cortical veins.
VA confirmed the presence of anastomotic circulation and the possibility of venous sacrifice. In 1 case the collateral retrograde flow was considered too slow (3 seconds of difference compared to other veins) and the vein was draining an eloquent area (primary motor cortex); thus it was considered unsuitable for a sacrifice. In 3 cases (2 tumors of the pineal region and 1 meningioma of the petrous apex) the test was performed on posterior fossa veins. In 1 case the postclipping ICG-VA showed stagnation of superior petrosal veins draining to the superior petrosal sinus (in the petrous apex meningioma), and therefore they were not sacrificed. In 2 cases of pineal region tumors the test was performed on supracerebellar veins, and it was in favor of venous sacrifice, confirming a collateral retrograde flow after temporary clipping. In 1 case (insular GBM) the test was performed on a large sylvian vein connecting temporal and frontal lobe venous systems: the postclipping ICG-VA showed good collateral vessel flow in frontal and temporal systems, and thus the bridging sylvian vein was sacrificed. In 1 case, the clipping test was performed on a vein located in the posterior median sulcus in the spinal cord (in a case of spinal ependymoma). In this case the clipping test was performed directly with bipolar forceps, and it showed no flow perturbation during the temporary occlusion; the vein could be therefore sacrificed to enlarge the opening of the posterior median sulcus to completely resect the intramedullary tumor.
The use of FLOW 800 to study venous flow before tumor resection (with or without the clipping test) allowed us to better identify the pattern of venous flow compared to classic ICG-VA, by analyzing the map of delay times and the characteristic flow curves in specific ROIs inside the veins.
Identification of the Posterior Median Sulcus in Spinal Cord Tumors. The ICG-VA was used in 7 cases of spinal cord tumors (5 ependymomas, 1 pilocytic astrocytoma, 1 enterogenic cyst) to better identify the posterior median sulcus to be opened for tumors not abutting the spinal cord surface, based on the position of posterior veins exiting the sulcus (Fig. 5) . We did not find a specific advantage for this utilization related to the use of FLOW 800 with the maps of delay time.
Postresection Survey. A postresection ICG-VA was performed in 41 cases (42 ICG-VAs). It was used in 16 cases (6 skull base meningiomas, 1 craniopharyngioma, 2 GBMs, 3 metastases, 3 chordomas, 1 giant angioma of the cavernous sinus) to check for patency of arteries directly encased by the tumor. In 12 cases (4 skull base meningiomas, 1 craniopharyngioma, 2 GBMs, 1 metastasis, 3 chordomas, and 1 giant angioma of the cavernous sinus) the ICG-VA confirmed arterial patency with no parenchymal flow disturbances. In 1 case of planum sphenoidalis meningioma infiltrating the optic chiasm and encasing bilaterally the internal carotid artery (ICA) and A 1 with their perfo-
FIG. 4.
Preresection and postresection survey in a patient with right parietal GBM. After dural opening the brain appeared swollen and congested. An arterialized flow in a cortical vein was noted (white arrow in A; inset shows preoperative MR image). A preresection survey was performed (B, C, G). The map of delay time (G) allowed us to identify a small area of faster cortical flow (asterisk) in the context of global congestion, and confirmed an AVF in a cortical vein (green vein shown with a large white arrow), and slower and retrograde flow in a more anterior vein related to brain congestion (small white arrow). The flow curve analysis in different ROIs (B, C) showed a low peak for parenchymal curves and slow time to peak, particularly in peripheral regions (curves 5-7), due to brain congestion. A postresection survey was completed after tumor resection (D-F, H). The map of delay times (H) showed the normalization of venous flow (large white arrow) and a faster parenchymal flow. The flow curve analysis (E, F) showed a steeper rise time compared to the preresection period, and a slower arterial-capillary difference in time to half-maximal fluorescence, indicating an improvement of brain flow in peritumoral areas.
rators, postresection ICG-VA with FLOW 800 analysis showed hypoperfusion in the optic chiasm, whereas ICA, A 1 , and brain cortex were normally perfused in the right hemisphere. The patient suffered severe vision problems due to optic chiasm damage, but no other neurological disturbances were evident in the postoperative period (Fig.  6) . In 1 case of right clinoid meningioma with encasement of ICA and middle cerebral artery (MCA), the MCA was damaged during tumor resection and had to be sacrificed. An emergency superficial temporal artery-MCA anastomosis was performed. The ICG-VA with FLOW 800 analysis showed bypass patency with no hypoperfusion in frontotemporal areas exposed by craniotomy. In 1 case of temporal metastasis, an artery completely encased by the tumor was sacrificed without flow perturbation. In 1 sylvian metastatic lesion, an M 4 branch was sacrificed and this resulted in hypoperfusion in primary motor cortex, as shown by the map of delay time and the evaluation of flow curves; the hypoperfusion was corrected by the use of a local intracranial-intracranial bypass. 3 Although the evaluation of arterial patency could be performed also by using the classic ICG-VA, the effect on brain perfusion could be better studied by the use of FLOW 800 analysis.
In 1 case (left temporal GBM), an unruptured posterior communicating artery (PCoA) aneurysm was incidentally discovered during tumor resection and it was clipped in the same surgical session. The ICG-VA was used to check for patency of PCoA and choroidal arteries after clipping, without a specific advantage related to FLOW 800 analysis. 5 In 10 cases (1 insular GBM, 2 cervical ependymomas, 5 parasagittal meningiomas, 1 hemangioblastoma, and 1 decompressive hemicraniectomy for edema and raised intracranial pressure after resection of multiple atypical LON, RON) . Even if at white-light microscopy examination (A) the optic chiasm appeared intact, the postresection ICG-VA (B) with FLOW 800 analysis (C) showed chiasmal hypoperfusion, whereas ICA and parenchyma were normally perfused. The patient suffered from severe vision problems due to optic chiasm damage, although no other neurological disturbances related to brain damage were evident in the postoperative period. F = frontal; T = temporal. meningiomas), 4 of which were further analyzed after previous studies performed for other indications (see previous paragraphs), ICG-VA with FLOW 800 analysis was performed postoperatively to directly assess brain or spinal cord perfusion even without artery manipulation during surgical maneuvers. In 5 parasagittal meningiomas, the same ICG-VA study and, more precisely, the use of maps of delay times and flow curve analysis based on FLOW 800 software allowed us to evaluate the patency and flow characteristics of the veins manipulated during resection. No flow perturbation could be found in this subgroup of patients.
In 8 cases (1 frontomesial anaplastic oligodendroglioma, 1 central neurocytoma, 5 meningiomas, 1 tumor of pineal gland region) ICG-VA with FLOW 800 analysis was performed to evaluate only venous patency and flow after tumor resection, in veins not studied in the preoperative survey (in 5 studies to assess cortical veins draining to the SSS, in 1 study to assess the patency of internal cerebral veins, in 1 study to assess direction of flow in superficial sylvian veins after sacrifice of a draining vein to the spheno-petrosal sinus, and in 1 study to assess the patency of precerebellar veins afferent to the vein of Galen). In all but 2 cases the veins were patent and with anterograde flow toward the sinuses (Fig. 7) ; in 1 case the portion of the vein directly connected to the SSS was occluded but with collateral retrograde flow, as evident on the map of delay times; in 1 case the sylvian vein drained in a retrograde way toward the Labbé system. In 1 case (1 meningioma), ICG-VA was performed to confirm the persistence of anastomotic circulation in veins after their sacrifice.
In 5 cases (3 GBMs, 1 metastasis, and 1 hemangioblastoma) ICG-VA with FLOW 800 analysis was performed postoperatively to study flow in veins that presented with an AVF before tumor resection. In all cases the postoperative survey with FLOW 800 analysis confirmed the normalization of venous flow after tumor resection (Figs. 3  and 4) .
Discussion
In 2011, we were the first to propose the use of classic ICG-VA during the resection of CNS tumors, based on a retrospective series of patients who were treated with resection in the period 2006-2008. 11 However, at that time, the technique for semiquantitative analysis of blood flow integrated in the surgical microscope was not available yet. With FLOW 800 software, a semiquantitative analysis of blood flow in the brain area exposed by the craniotomy could be performed. In particular, the algorithm integrated in the surgical microscope is able to reconstruct maps of gray intensity based on the average AIs of infrared fluorescence detected by the microscope camera, and maps of delay time based on the time needed to reach 50% of the maximal fluorescence intensity. In addition, it is possible to study in multiple ROIs the curves of fluorescence detected by the camera over the time of ICG-VA registration.
Kamp et al. were the first authors to explore the use of microscope-integrated quantitative analysis of ICG-VA for blood flow assessment. 24 These authors studied 30 patients with only vascular pathologies, and they were the first to hypothesize the possibility of using the different parameters derived from FLOW 800 analysis in clinical applications. In particular they showed that the maps of delay time appeared to be of great value, in giving an immediate representation of blood flow perturbation in cortical areas, either as an effect of the disease itself, or related to iatrogenic damage to arteries manipulated in the surgical approach. Despite several applications of ICG-VA that have been described so far, 8, 9, 16, 23, 25, 28, [30] [31] [32] 34, 35, 39, 40 it is remarkable to note the paucity of articles reporting its use, along with quantitative analysis to explore cerebral perfusion in the intraoperative setting. 38, 41 Even less interest could be found in the context of surgery for brain tumors, where only cerebral and spinal hemangioblastomas have been studied. 6, 20, 37 In 2009 we acquired the technology to use the FLOW 800 algorithm for flow analysis in both vascular and tumor cases. We identified 73 tumor cases in which ICG-VA was used, and in which both surgical reports and videos were available for retrospective analysis, in patients treated between May 2011 and December 2017. Thus, only approximately 5% of the entire tumor population that was surgically treated in the same period was selected for ICG-VA. Our population consisted of a heterogeneous group of cerebral and spinal tumors, represented mainly by meningiomas and high-grade gliomas. The most frequent application for ICG-VA was in a postresection survey, in particular to assess arterial and venous patency and brain perfusion after tumor resection. In 87.5% of the cases the postresection survey confirmed arterial and venous patency and the absence of local hypoperfusion, thus providing assurances on the low risk of postoperative complications related to vessel manipulation. On the contrary, in the remaining 12.5% of the cases the postoperative survey showed local hypoperfusion directly related to vessel manipulation. In 2 of these cases, the intraoperative recognition of this complication allowed the surgeons to perform surgical maneuvers to reverse the local hypoperfusion and reduce the risk of postoperative complications.
3 Even though a similar experience could be attained also with classic ICG-VA, as already reported in our previous paper and in a similar study by other authors, 11,27 the use of blood flow analysis by FLOW 800 software allowed us to better interpret the brain perfusion, particularly with the maps of delay times, as indicated also in vascular experience (Figs. 3, 4, 6 , and 7). 24 The preoperative survey, performed in 27 cases, was used to identify both specific tumor-related pathophysiological vascular changes and nonspecific mass-effect changes. This was particularly important in GBM and hemangioblastomas, in which the superficial vascular pattern and the presence of AVFs could be clearly shown (Figs. 3   and 4) . The possibility of identifying the feeding arteries and the tumor nodule in hemangioblastomas was reported also by Hojo et al. in 2014, 20 but mainly with classic ICG-VA. However, we also believe that for this application the use of semiquantitative flow analysis improved and simplified the interpretation of videoangiographic data. Furthermore, preoperative survey and long recording time allowed us to concentrate our attention on the venous flow and, when needed, to perform a temporary clipping test to decide whether or not the vein could be sacrificed to enlarge the surgical corridor or completely resect the tumor, as shown by our group in a preliminary experience in 8 cases.
14 We never performed an arterial clipping test for arterial sacrifice, as proposed by Kim and Cohen-Gadol in 2013, 26 but we also believe that this application could be expanded in the future. An innovation compared to previous experiences was also the use of ICG-VA in spinal tumors as a way to help in posterior median sulcus identification when the tumor was not abutting spinal cord survey, and when, due to edema and congestion, the normal anatomy was distorted and the sulcus was difficult to find with white-light illumination. We were also able to show, in very select cases (only 6 cases in our series), that an extradural survey was feasible, and that allowed identification of both dural sinus and cortical vein courses, thus helping in dural opening, as already shown by Nussbaum et al. 29 We are aware of the fact that our study is only a retrospective evaluation of the different application of ICG-VA with FLOW 800 analysis, in a limited series of patients with CNS tumors, based on the specific experience of our group. In addition, we did not perform any comparison with other techniques of blood flow monitoring, and thus we could not provide any measurement about sensitivity and specificity. However, we believe that the results of this paper underline the concept that the surgery of brain tumors is also a surgery of brain vessels, and that understanding the pathophysiological changes of the brain circulation that are directly related to the tumor presence and sometimes to the surgical manipulation, as derived by flow analysis provided by ICG-VA, could be associated with better surgical results in selected cases.
Conclusions
We found ICG-VA with FLOW 800 to be a useful method to monitor blood flow in the exposed vessels and parenchyma during microsurgical removal of CNS tumors in selected cases. In particular a preresection survey provides useful information about pathophysiological changes of brain vasculature related to the tumor and individuates helpful landmarks for the surgical approach, and the postresection survey helps to prevent potential complications associated with the resection (such as local hypoperfusion or venous infarction). Future studies with a larger tumor population should be performed to confirm all the potential advantages of this technique in the surgical management of CNS tumors.
